Efficacy of mirabegron, a β 3 ‐adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post‐hoc analysis of pooled data from two randomized, placebo‐controlled, double‐blind studies-Reference-Cited by-同舟云学术

Efficacy of mirabegron, a β 3 ‐adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post‐hoc analysis of pooled data from two randomized, placebo‐controlled, double‐blind studies

Published:2021-10-04 Issue:1 Volume:29 Page:7-15
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Takahashi Satoru¹^ORCID,Mishima Yuji²^ORCID,Kuroishi Kentaro³^ORCID,Ukai Masashi²^ORCID

Affiliation:

1. Department of Urology Nihon University Japan

2. Medical Affairs Astellas Pharma Inc. Japan

3. Data Science, Development Astellas Pharma Inc. Tokyo Japan

Funder

Astellas Pharma

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14700

Reference28 articles.

1. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study

2. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries

3. Assessment of bothersomeness and impact on quality of life of urinary incontinence in women in France, Germany, Spain and the UK

4. Effect of Bothersome Overactive Bladder Symptoms on Health-related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS

5. Economic Burden of Urgency Urinary Incontinence in the United States: A Systematic Review

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of mixed urinary incontinence: IUGA committee opinion;International Urogynecology Journal;2024-01-22

2. Current optimal pharmacologic therapies for overactive bladder;Expert Opinion on Pharmacotherapy;2023-10-05

3. Mixed Urinary Incontinence: Diagnosis and Management;OBM Geriatrics;2023-10-05

4. Mirabegron in the Management of Overactive Bladder Syndrome;International Journal of Women's Health;2022-09

5. Mirabegron attenuates porcine ureteral contractility via α1-adrenoceptor antagonism;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-04-21